Akebia Therapeutics, Inc.

AKBA us
$0.90
▼ 0.02 (-2.48%)
Volume: 4,374,462 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 36
  • 21d momentum -1.1%
  • MA aligned bearish
  • RSI 43
🎯 Pullback 62
  • Near lower Bollinger band
  • -4.7% vs 20MA
💎 Value 58
  • -72% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)42.7
MACD+0.003
MA trendBearish
ATR6.50%
21d mom.-1.1%
63d mom.-21.4%
vs 20MA-4.7%
RVOL(20)0.54×
52w low · 1 52w high · 3
-72.0% from 52-week high
20d support 1 · resistance 1

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$255M
PER—
PBR10.19
PSR1.16
EPS$-0.11
ROE-118.6%
ROA-8.5%
Dividend yield0.00%
Debt/Equity1.98
EV/EBITDA-12.81
week1M3M6M1YYTD
-2.13% -1.14% -21.39% -35.53% -67.65% -42.18%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
3/10
🐻 Bear
9/10

14d momentum -8.05%, daily vol 3.73%. Akebia Therapeutics, Inc. sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.